Taiwan News1d
Vietnam Active Pharmaceutical Ingredients Market to Reach $728.10 Million by 2030, Growing at 7.42% CAGR
Market was valued at USD 472.77 Million in 2024 and is expected to reach USD 728.10 Million by 2030, growing at a CAGR of 7.42% during the forecast period. The market is being driven by the increasing ...
Taiwan News1d
Vietnam Pharmaceuticals Market to Reach $12.12 Billion by 2033, Growing at 7.96% CAGR
The Vietnam Pharmaceuticals Market was valued at USD 7.60 billion in 2024 and is projected to reach USD 12.12 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.96% during the ...
ScandAsia9d
Eurocham discusses trade and investment with Vietnam’s Prime Minister
EuroCham Vietnam engaged in high-level discussions with Prime Minister Pham Minh Chinh on Sunday 2 March 2025, addressing key ...
Vietnam Investment Reviev9d
Pharma trading landscape undergoing significant shift
Such groups include AstraZeneca Vietnam, which has committed to investing approximately $220 million in the country over the ...
VietNamNet16d
Calls for draft decree on pharmacy law amendments to make it easier for business
Nguyễn Lan Hương from Sanofi Vietnam JSC emphasised the need to review regulations on managing drug imports, without a circulation registration certificate in Việt Nam. Hương suggested that drugs ...
Pharmaceutical Technology16d
Sanofi’s Sarclisa combo approved in Japan for newly diagnosed MM
Sanofi’s Sarclisa has received approval in more than 50 nations and regions. Credit: LCV/Shutterstock. Sanofi’s Sarclisa (isatuximab) has gained approval from Japan’s Ministry of Health, Labour and ...
Benzinga.com18d
Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease
In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic ...
philstar.com21d
EDITORIAL - Preventing dengue
It is one of just two dengue vaccines approved by the WHO, the other one being Sanofi-Pasteur’s Dengvaxia, which became mired in controversy in the Philippines and caused strong vaccine ...
Channel NewsAsia Singapore23d
Vietnam parliament approves US$8 billion rail link to China
HANOI: Vietnam's parliament on Wednesday (Feb 19) approved plans for an US$8 billion rail link from its largest northern port city to the border with China, boosting links between the two ...
Pharmaceutical Technology23d
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Image credit: Shutterstock / Leitenberger Photography. Sanofi’s sale of its $17bn consumer health business Opella just advanced a step closer, after the drugmaker signed a share purchase agreement ...
vietnam-briefing23d
Vietnam’s New VAT Law: Key Compliance Guidance
We examine Vietnam’s new Value Added Tax (VAT) Law, set to take effect on July 1, 2025, which introduces significant changes to the country’s VAT regime. Recent clarifications are outlined in Official ...